Archive ready

乾燥細胞培養痘そうワクチンの効能追加承認について｜厚生労働省

https://www.mhlw.go.jp/stf/newpage_27201.html

April 10, 2026 at 03:01 AM JST•The archive page, viewer, and downloads use this saved version.

April 10, 2026 at 03:01 AM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

乾燥細胞培養痘そうワクチンの効能追加承認について｜厚生労働省

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.mhlw.go.jp/stf/newpage_27201.html

StartedApril 10, 2026 at 03:01 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page announces the Japanese Ministry of Health, Labour and Welfare's approval of an additional indication for dried cell culture smallpox vaccine on August 2, 2022. KM Biologics Co., Ltd.'s product "Dried Cell Culture Smallpox Vaccine LC16 'KMB'" received approval for monkeypox prevention in addition to its existing smallpox prevention indication. The application was submitted on July 6, 2022, and the approved efficacy now covers prevention of both smallpox and monkeypox.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.